The global blood warmer devices market is on a robust growth trajectory, with an estimated valuation of USD 451.2 million in 2022. The market is projected to expand significantly, reaching approximately USD 937.5 million by the end of 2032, reflecting a compound annual growth rate (CAGR) of 7.6% over the forecast period.
Key drivers of this growth include advancements in medical technology and increasing demand for effective blood warming solutions in clinical settings. Intravenous warming systems, a leading product category, held a dominant market share of approximately 47.1% in 2021, underscoring their critical role in patient care.
Hypothermia has become very common and causes major complications, this is driving the demand for blood warmer devices. Since these devices can help in preventing complications during the blood transfusion process the demand is expected to grow in the future. Companies are also investing in the research and development of portable and smart blood-warming devices. Manufacturers are also working on new business strategies to launch a new product. Partnerships and collaborative activities are also on the rise. The demand for disposable blood and fluid warmer devices is also increasing, due to the rise in some complications.
Key Market Players Competing to Sustain in the Market
The report offers a detailed profile of some of the key market players in the Global Blood Warmer Devices Industry such as 3M Company, Smiths Medical, The 37 Company, GE Healthcare, Emit Corporation, Stryker Corporation, Geratherm Medical, Barkey GmbH & Co. KG, Stihler Electronic GmbH, Biegler GmbH, Belmont Instrument, Keewell Medical Technology Co. Ltd., and Baxter International Inc. (Gambro). These key players are continuously working on new business strategies to offer better products and compete in the global market.
Forecast Highlights on the Blood Warmer Devices Market
The Global Blood Warmer Devices Industry is segmented based on end-user, product type, application, and region. Based on the product type, the segment includes intravenous warming systems, surface warming systems,s, and blood warming accessories. Among these, surface warming system is expected to be the widely accepted product in the global blood-warmer devices market. By the end of 2026, the surface warming system is estimated to surpass US$ 100 million in revenue.
Based on end users, the segmentation consists of hospitals, blood banks, home care settings, and others. Hospitals are expected to be the largest users of blood warmer devices. By the end of 2017, hospitals are estimated to account for nearly two-thirds of the revenue share.
Based on the application, the market is segmented into home care, preoperative care, acute care, newborn care, and other applications. Blood warming devices are expected to find the largest application in preoperative care. By the end of 2026, the preoperative care segment is estimated to reach nearly US$ 100 million in revenue.
Geographically, the market is segmented into Europe, North America, Japan, Asia Pacific Excluding Japan (APEJ), the Middle East and Africa (MEA), and Latin America. Among these, North America is expected to dominate the Global Blood Warmer Devices Industry during the forecast period 2017-2026. The increasing occurrence of hypothermia among the aging population and infants in the U.S. is one of the factors driving the growth in North America. Growth in trauma cases and surgeries is also contributing to the growth of the market in the region.
A Old Full Report Analysis Click Here
\Blood Warmer Devices Market Taxonomy
Region
- North America
- Latin America
- Europe
- Japan
- APEJ
- MEA
Product Type
- Intravenous Warming System
- Surface Warming System
- Blood Warming Accessories
End User
- Hospitals
- Blood Banks
- Home Care Settings
- Other End Users
Application
- Preoperative Care
- Home Care
- Acute Care
- New Born Care
- Other Applications
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube